Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients
Clinical trial NCT04293393 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04293393
- Sponsor
- Spanish Breast Cancer Research Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-02
- Primary completion
- 2023-06-21
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.